Ingersoll Rand Reports Strong Q4 & Full-Year 2025 Results, Issues Positive 2026 Guidance
summarizeSummary
Ingersoll Rand reported strong Q4 and full-year 2025 financial results, with double-digit revenue growth in Q4 and positive adjusted earnings. The company also issued optimistic 2026 guidance, projecting continued growth in revenue and adjusted earnings per share.
check_boxKey Events
-
Strong Q4 and Full-Year 2025 Financial Performance
Ingersoll Rand reported Q4 2025 orders up 8% to $1,952 million and revenues up 10% to $2,091 million. Adjusted net income per share increased 14% to $0.96. For the full year 2025, orders grew 9% to $7,716 million and revenues increased 6% to $7,651 million, with Adjusted net income per share up 2% to $3.34.
-
Positive 2026 Financial Guidance Issued
The company provided full-year 2026 guidance, expecting revenue growth of 2.5% to 4.5%, Adjusted EBITDA between $2,130 million and $2,190 million (up 2% to 5%), and Adjusted EPS in the range of $3.45 to $3.57 (up 3% to 7%).
-
Robust Cash Flow and Capital Allocation
Ingersoll Rand generated $499 million in operating cash flow and $462 million in free cash flow during Q4 2025. For the full year, operating cash flow was $1,356 million and free cash flow was $1,220 million. The company returned $1,050 million to shareholders in 2025 through share repurchases and dividends.
-
Strategic M&A Activity Continues
The company deployed $65 million to M&A in Q4 2025 and, in January 2026, acquired Scinomix, Inc., a manufacturer of technologies for streamlining automation workflows in life sciences.
auto_awesomeAnalysis
Ingersoll Rand Inc. delivered robust financial results for both the fourth quarter and full-year 2025, demonstrating strong operational execution in a complex global environment. The company reported significant growth in orders, revenue, and adjusted earnings, driven by its competitive differentiator, Ingersoll Rand Execution Excellence (IRX). The positive momentum is expected to continue into 2026, supported by a solid guidance range for revenue, Adjusted EBITDA, and Adjusted EPS. The company's strong liquidity position and active capital allocation strategy, including share repurchases and strategic M&A, further underscore its financial health and growth prospects.
At the time of this filing, IR was trading at $95.50 on NYSE in the Technology sector, with a market capitalization of approximately $37.2B. The 52-week trading range was $65.61 to $100.00. This filing was assessed with positive market sentiment and an importance score of 7 out of 10.